The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs.

www.science.org/doi/10.1126/...

Likewise, screening for FQ resistance may inform what breakthrough infections will occur and optimize early management.

Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.

Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs

onlinelibrary.wiley.com/doi/10.1111/...

The future may be using the tool to look at pathogen and host response in the same assay - multiple examples shown that the combined approach provided answers that wouldn’t have been identified.

Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.

Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.

Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID

It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!

A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal

Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1

Great talk about HHV8 and the role of donor screening by Alesandra Mularone including follow-up management.

linkinghub.elsevier.com/retrieve/pii...

Join Hans Hirsch & I for our next ESGICH-ESGREV Webinar on the Management of Respiratory Viral Infections in the Immunocompromised. 3 amazing speakers and time for questions and discussion about challenging cases.

Tuesday December 10 at 5pm CET

Register today: https://buff.ly/4idBQhV

Key reminder - COVID-19 is still around. I had super mild symptoms and tested because we had plans for a dinner party later tonight! As we all plan to travel and visit family - test if you have any respiratory symptoms and isolate - many you’ll be visiting may be at higher risk of severe dz!

Want to learn about the treatment of RVI in immunocompromised patients?

Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI.

Chairs: Hans Hirsch and @michaelisonmd.bsky.social

Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja